Summary
- Revenue
- DAWN current annual revenue is $158.18M, up +20.60% year-over-year
- Next Earnings
- As of today, the next earnings release for DAWN has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Day One Biopharmaceuticals Inc |
| Ticker | NASDAQ: DAWN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | dayonebio.com |
| Employees | 178 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | - | |
| Price, 1D Change | - | |
| - | ||
| - | ||
| - | ||
| - | N/A | |
| $158.18M | ||
| Revenue, 1Y Change | +20.60% | |
| -$1.04 | ||
| EPS, 1Y Change | -1.52% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.04 | ||
| EPS Estimate | -$0.76 | N/A |
| EPS Est. Change | +27.39% | N/A |
| $158.18M | ||
| Revenue Estimate | $240.45M | N/A |
| Revenue Est. Change | +52.01% | N/A |
| Current Price | - | |
| Price Target | $21.50 | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.67 | -$1.02 | -52.61% | |
| -$0.91 | -$1.04 | -13.89% | |
| -$0.76 | N/A | +27.39% | |
| -$0.04 | N/A | +95.89% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $122.52M | $131.16M | +7.05% | |
| $153.58M | $158.18M | +2.99% | |
| $240.45M | N/A | +52.01% | |
| $308.14M | N/A | +94.80% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | - | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $158.18M | ||
| -$1.04 | ||
| $140.97M | ||
| 89.12% | ||
| -$127.75M | ||
| -80.76% | ||
| -$107.32M | ||
| -67.85% | ||
| -$123.96M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.01 | ||
| 8.02 | ||
| 7.91 | ||
| - | ||
| 3 | ||
| - |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $441.16M | ||
| $441.11M | ||
| $507.83M | ||
| $485.10M | ||
| $66.67M | ||
| $60.52M | ||
| $2.79M | ||
| $174.00K | ||
| $3.73M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $265.50M | ||
| $268.72M | ||
| $17.21M | ||
| $0.00 | ||
| $3.79M | ||
| $0.00 | ||
| -$1.98M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$103.76M | ||
| $174.65M | ||
| $1.22M | ||
| $3.82M | ||
| -$107.58M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| JP Morgan | → | |
| HC Wainwright & Co. | → | |
| Wedbush | → | |
| Needham | → | |
| Jones Trading | → | |
| Wedbush | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| TD Cowen | ||
| Needham | → |
Analyst sentiment
Institutional ownership
No data
Screeners with DAWN
FAQ
- What is the ticker symbol for Day One Biopharmaceuticals Inc?
- The ticker symbol for Day One Biopharmaceuticals Inc is NASDAQ:DAWN
- Does Day One Biopharmaceuticals Inc pay dividends?
- No, Day One Biopharmaceuticals Inc does not pay dividends
- What sector is Day One Biopharmaceuticals Inc in?
- Day One Biopharmaceuticals Inc is in the Healthcare sector
- What industry is Day One Biopharmaceuticals Inc in?
- Day One Biopharmaceuticals Inc is in the Biotechnology industry
- What country is Day One Biopharmaceuticals Inc based in?
- Day One Biopharmaceuticals Inc is headquartered in United States
- When did Day One Biopharmaceuticals Inc go public?
- Day One Biopharmaceuticals Inc initial public offering (IPO) was on May 27, 2021
- Is Day One Biopharmaceuticals Inc in the S&P 500?
- No, Day One Biopharmaceuticals Inc is not included in the S&P 500 index
- Is Day One Biopharmaceuticals Inc in the NASDAQ 100?
- No, Day One Biopharmaceuticals Inc is not included in the NASDAQ 100 index
- Is Day One Biopharmaceuticals Inc in the Dow Jones?
- No, Day One Biopharmaceuticals Inc is not included in the Dow Jones index
- When was Day One Biopharmaceuticals Inc last earnings report?
- Day One Biopharmaceuticals Inc's most recent earnings report was on May 5, 2026
- When does Day One Biopharmaceuticals Inc report earnings?
- The date for Day One Biopharmaceuticals Inc's next earnings report has not been announced yet
Data Sources & References
- DAWN Official Website dayonebio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1845337/000119312526066956/0001193125-26-066956-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1845337/000119312526066956/0001193125-26-066956-index.htm
- DAWN Profile on Yahoo Finance finance.yahoo.com/quote/DAWN
- DAWN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dawn
